Lindbrook Capital’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-32
Closed -$1.63K 2960
2024
Q4
$1.63K Sell
32
-21
-40% -$1.03K ﹤0.01% 2362
2024
Q3
$2.19K Sell
53
-154
-74% -$7.39K ﹤0.01% 2313
2024
Q2
$9.97K Buy
207
+169
+445% +$7.49K ﹤0.01% 1631
2024
Q1
$1.82K Sell
38
-55
-59% -$2.94K ﹤0.01% 2274
2023
Q4
$6.04K Buy
93
+21
+29% +$1.26K ﹤0.01% 1786
2023
Q3
$4.71K Buy
72
+30
+71% +$1.89K ﹤0.01% 1794
2023
Q2
$2.44K Sell
42
-21
-33% -$1.32K ﹤0.01% 2073
2023
Q1
$3.89K Sell
63
-81
-56% -$4.86K ﹤0.01% 1961
2022
Q4
$9.15K Sell
144
-21
-13% -$1.52K ﹤0.01% 1476
2022
Q3
$12K Buy
165
+20
+14% +$1.49K ﹤0.01% 1258
2022
Q2
$10K Buy
145
+11
+8% +$791 ﹤0.01% 1274
2022
Q1
$12K Sell
134
-312
-70% -$25.5K ﹤0.01% 1233
2021
Q4
$41K Buy
+446
New +$38.2K 0.01% 787

Other funds holding NARI

Lindbrook Capital's NARI Position: Q1 2025 in Review

Lindbrook Capital sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 32 shares — an estimated $1.63K sold.

Lindbrook Capital first reported a position in NARI in Q4 2021 and held it in 13 quarters. The position peaked at $41K in Q4 2021. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Lindbrook Capital reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Lindbrook Capital sold 32 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $1.63K.
  • Lindbrook Capital first reported a position in Inari Medical, Inc. Common Stock in Q4 2021 and held it in 13 quarters.
  • Lindbrook Capital's Inari Medical, Inc. Common Stock position peaked at $41K in Q4 2021.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.